Nancy Klauber-DeMore Selected Research

WD repeat containing planar cell polarity effector

5/2021	Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma.
11/2017	Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis.
1/2017	Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma.
1/2014	Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.
5/2013	A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.
5/2008	Molecular characterization of human breast tumor vascular cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy Klauber-DeMore Research Topics

Disease

17	Neoplasms (Cancer) 12/2019 - 05/2003
11	Breast Neoplasms (Breast Cancer) 09/2021 - 05/2003
4	Hemangiosarcoma (Angiosarcoma) 12/2019 - 05/2013
3	Neoplasm Metastasis (Metastasis) 05/2021 - 08/2005
2	Triple Negative Breast Neoplasms 12/2019 - 05/2013
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2021
1	Lobular Carcinoma 09/2021
1	Osteosarcoma (Osteogenic Sarcoma) 05/2021
1	Postoperative Pain 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Lymphatic Metastasis 05/2006
1	Neoplasm Micrometastasis 05/2006
1	Residual Neoplasm 08/2005

Drug/Important Bio-Agent (IBA)

6	WD repeat containing planar cell polarity effectorIBA 05/2021 - 05/2008
3	Monoclonal AntibodiesIBA 05/2021 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2008
2	transcription factor NF-AT c3IBA 11/2017 - 05/2013
2	CalcineurinIBA 11/2017 - 05/2013
2	AntibodiesIBA 01/2017 - 05/2008
2	StreptavidinIBA 01/2017 - 01/2014
1	Immune Checkpoint InhibitorsIBA 05/2021
1	Immunoglobulin G (IgG)IBA 05/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Narcotics (Narcotic Analgesics)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	AntioxidantsIBA 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	EpitopesIBA 01/2019
1	InterferonsIBA 01/2018
1	Connexin 43 (Connexin43)IBA 12/2017
1	Pharmaceutical PreparationsIBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	ConnexinsIBA 12/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2017
1	NFATC Transcription FactorsIBA 11/2017
1	IgYIBA 01/2017
1	Contrast MediaIBA 01/2014
1	CateninsIBA 05/2013
1	Bevacizumab (Avastin)FDA Link 05/2013
1	Factor VIII (Coagulation Factor VIII)IBA 05/2008
1	Phenobarbital (Luminal)FDA Link 05/2008
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 05/2008
1	Janus Kinase 3IBA 05/2008
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2007
1	2-MethoxyestradiolIBA 01/2007
1	Estrogen ReceptorsIBA 01/2006
1	Coloring Agents (Dyes)IBA 05/2003
1	Technetium Tc 99m Sulfur Colloid FDA Link 05/2003

Therapy/Procedure

5	Therapeutics 05/2021 - 05/2008
4	Segmental Mastectomy (Lumpectomy) 09/2021 - 02/2007
3	Radiotherapy 04/2011 - 02/2007
2	Neoadjuvant Therapy 05/2006 - 08/2005
1	Microbubbles 01/2017
1	Simple Mastectomy 04/2011
1	Lasers (Laser) 05/2008
1	Mastectomy (Mammectomy) 02/2007
1	Drug Therapy (Chemotherapy) 05/2006
1	Aftercare (After-Treatment) 05/2006
1	Lymph Node Excision (Lymph Node Dissection) 05/2003